10% Cost 1,631 1,509 Gross profit 209 164 45 28% Gross profit margin 11.3% 9.8% Other income 6 2 4 246% Selling & Admin expenses 123 121 2 2% 6.7% 7.2% Cost and expense from delayed project 57 (57

Financial Cost 0.93 0.23 4.37 1.25 -3.44 -78.66 Profit (loss) before income tax expenses -55.59 -13.80 -82.86 -23.65 27.26 -32.90 Income tax (expense) revenue 4.89 1.21 0.33 0.09 4.56 -1,400.10 Actuarial gain

[1Q20 VS. 4Q19] [1Q20 VS. 1Q19] FX: THB/USD 31.1053 30.0127 31.3204 Sales Revenue, THB 3,259.7 2,902.4 +12.3% 3,113.9 +4.7% [ Sales Revenue, USD $104.8 $96.7 +8.4% $99.4 +5.4% ] Cost of Sales 2,477.7

Profit / Cost of Sales Analysis and Sales and Administration Analysis Gross Profit increased by THB 339 million with the gross margin being 15% in 2017 up 1 percentage point from 14% in 2016, due to higher

the employee benefits obligations approximately Baht 5.90 million. These were divided into two sections 1). cost of hospital operations in amounts of Baht 3.78 million. selling expense in amounts of

profitability and cost reduction of selling and administrative expense due to increased efficiency control. Net profit in the fiscal year 2018 was Baht 1,008 million, decreased by Baht 435 million or 30.1% from

as mentioned above, the Company’s sales revenue was Baht 139.11 million. It decreased Baht 138.71 million or equivalent to 49.93% compared to previous year. Cost of goods sold amount to Baht 75.41

as expenses from setting Corporate shops / consolidation in the Flexiglass’ expense (the new acquisition in that recently acquire in the beginning of 2018) / Research and development cost in new

company had an strictly and effective stock management and cost control of raw material. Expense In the first quarter of 2020, the company had the selling cost of 5.12 million baht, decreased by 3.35

in subsidiary - (25) 25 100.00 Loss on exchange rates (4,456) (2,971) (1,485) 49.98 Profit (loss) before finance cost and income tax expense 5,403 (4,952) 10,355 209.11 Finance cost (2,962) (485